miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.
about
The regulation of hematopoietic stem cell populationsTherapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAsThe Antibiotic Drug Tigecycline: A Focus on its Promising Anticancer PropertiesOvercoming therapeutic resistance in glioblastoma: the way forwardStemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment.CD244 maintains the proliferation ability of leukemia initiating cells through SHP-2/p27kip1 signaling.MiR144/451 Expression Is Repressed by RUNX1 During Megakaryopoiesis and Disturbed by RUNX1/ETO.Understanding of leukemic stem cells and their clinical implications.Global proteomics dataset of miR-126 overexpression in acute myeloid leukemia.A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.Biology and relevance of human acute myeloid leukemia stem cells.Cell cycle regulation of hematopoietic stem or progenitor cells.MicroRNAs in Control of Stem Cells in Normal and Malignant Hematopoiesis.Cancer stem cell signaling pathways.Targeting acute myeloid leukemia stem cell signaling by natural products.Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?A Novel High-Throughput Screening Platform Reveals an Optimized Cytokine Formulation for Human Hematopoietic Progenitor Cell Expansion.Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia.MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia.mTOR signaling in stem and progenitor cells.miR-99 regulates normal and malignant hematopoietic stem cell self-renewal.Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia.A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia.MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies.A 17-gene stemness score for rapid determination of risk in acute leukaemia.RUNX1-ETO Leukemia.JAM3 maintains leukemia-initiating cell self-renewal through LRP5/AKT/β-catenin/CCND1 signaling.MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.miR-126 suppresses epithelial-to-mesenchymal transition and metastasis by targeting PI3K/AKT/Snail signaling of lung cancer cells.Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.Continuous biomarker monitoring by particle mobility sensing with single molecule resolution.Abnormal microRNA expression in the course of hematological malignanciesBiological Aspects of mTOR in Leukemia
P2860
Q26740666-66A6A96A-5FC3-47E1-AA71-966EA2D77339Q28071427-E489E4C4-04B0-4001-AD4B-AAF7A2A9162EQ28076402-A34BB85C-0F25-4526-9DA2-F45CBFFB7EEEQ29248396-C2477ED6-8653-4CA7-8D50-8D71D103DB49Q33572252-1B886B6A-9372-4C24-B066-6618CCA4C86EQ33574172-DE0D0014-F560-4FC5-B09E-3A82BAE51A95Q35962533-10A9BEF6-FBDD-4314-91FF-2A8BB747518CQ37616010-766BC762-3166-4D82-A242-77D172AB6460Q38387263-0A81DBC9-2A46-4B96-BECC-4A01F2E8724EQ38637596-D7075EFD-5414-4AD3-87CE-69E2539A435BQ38761783-B39110B8-61D4-4293-B63D-880B3BD146A5Q38809621-37179288-698E-4409-B328-E1A1714CC12CQ38933683-0BF2B3CA-DCF8-47CD-B6F8-1BA1FD54F9B6Q38950221-858FC241-A13A-46BF-AED5-FF34161486E1Q39109921-A3CF63AE-2547-402C-AFA6-B839157AB0AEQ39406956-33ECFB2F-7B63-4073-B756-8FAA35D714A6Q43258035-2BC9DDFA-00F9-4126-BBF2-D7FEC3B284F9Q47347914-98E8049D-AE21-4344-9B3E-7CCAAB7D809DQ48104779-74306217-2EAF-4982-A658-2ED4F8FA52A5Q48293926-EBBEAA52-CFBB-4338-9426-37BEE64762D2Q48364240-8C344538-C7A1-47AD-9057-81CF7A24428FQ48649399-EEED79C8-684B-4EFB-8DFC-034CEEA2B5F5Q49302828-199A3530-E86A-40ED-A5CF-42DCC8DB203FQ49521797-A7AE0281-7BAF-4068-8870-52F4E7012FC4Q50538514-A801812A-CE5B-43B2-AC01-1C528A466789Q51097627-C105687C-B4DB-47DF-BF12-6AB8EF2AE875Q52628082-D5D2335A-2319-4AD2-8D6F-04B395AD56DEQ52655669-09207E2B-7543-4C62-841A-04F4699CDC4CQ54090238-AADA9426-BF2A-42A9-9084-1BF941167769Q55026357-E5160938-BD8B-457B-8B6E-03171993D041Q55452015-5FFF0745-CFB4-4A81-B2AD-D7F386BF8D2BQ57817341-E2968A11-87C8-46FE-A97B-9173B5031C86Q58780065-04DF0445-A01B-49D6-BC75-3B419CDB2C07
P2860
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
miR-126 Regulates Distinct Sel ...... nant Hematopoietic Stem Cells.
@ast
miR-126 Regulates Distinct Sel ...... nant Hematopoietic Stem Cells.
@en
type
label
miR-126 Regulates Distinct Sel ...... nant Hematopoietic Stem Cells.
@ast
miR-126 Regulates Distinct Sel ...... nant Hematopoietic Stem Cells.
@en
prefLabel
miR-126 Regulates Distinct Sel ...... nant Hematopoietic Stem Cells.
@ast
miR-126 Regulates Distinct Sel ...... nant Hematopoietic Stem Cells.
@en
P2093
P2860
P50
P1433
P1476
miR-126 Regulates Distinct Sel ...... nant Hematopoietic Stem Cells.
@en
P2093
Aaron Trotman-Grant
Amanda Mitchell
Benjamin L Ebert
Björn Nilsson
Eric R Lechman
Erwin M Schoof
Fabio Ciceri
Gabriela Krivdova
James A Kennedy
Janneke Elzinga
P2860
P304
P356
10.1016/J.CCELL.2015.12.011
P577
2016-01-20T00:00:00Z